This work is licensed under creative common license: http://creativecommons.org/licenses/by-nc-nd/4.0/ © MJSBH 2018 ABSTRACT Introduction: Cardiovascular disease (CVD) is one of the leading causes of mortality and morbidity in both developed and developing countries. CVD risk rises to double fold in women after menopause. We aim to stratify menopausal women of our region for having coronary heart disease in next 10 years.
INTRODUCTION
Cardiovascular disease (CVD) has been the leading cause of mortality and morbidity of both men and women in developed as well as developing countries. CVD refers to disease affecting blood vessels and heart; and usually atherosclerosis associated. 1 Atherosclerotic plaques are thickened intima with various mixtures of fibrous tissues, cells, and lipid deposition with chronic inflammation. 2-4 CVD risk factors are categorised into major independent risk factors and predisposing factors including several lifestyle variables and laboratory parameters. 5 The incidence and prevalence of coronary artery disease varies with the life cycle of women. The risk is lower in p r e m e n o p a u s a l s t a t e a n d i n c r e a s e s i n postmenopausal state. The offspring's of F r a m i n g h a m h e a r t s t u d y w h o w e r e gynaecologically normal, and were not taking any hormones showed that menopause is positively correlated with LDL cholesterol and decreased LDL particle size. 6 CVD accounts for one third of all deaths and the rate is even higher for South Asian women. 7 In country like Nepal, elderly women are under privileged, less literate, less health aware and health professionals are weakly concerned of advancing cardiovascular risk in this age group. American Heart Association (AHA) survey reveals that many (38%) women underestimate the importance of CVD risk and that this issue is not often discussed.
This loses the opportunity to prevent CVD mortality and morbidity by lifestyle modifications. 8 Our study sets out to identify the risk score using Framingham risk assessment tool to predict the chance of having coronary heart disease in next 10 years. Here the subjects will get a chance to look at their future risk of developing coronary heart disease and the chance for timely intervention like life style modification and therapeutic intervention to prevent cardiovascular event. having > 211 mg/dL and one subject from this group had high risk score ( Original Article ! Coronary Heart Disease in Postmenopausal Women; Bajracharya S et al.
METHODS
n= 163 had HDL-C < 39 and n = 1 (t = 163) had high risk score (Table 4) .
DISCUSSION
Several studies on increasing cardiovascular risk in post-menopausal women put insight in importance of early screening and timely intervention for primary prevention. Here in this study Framingham
Risk assessment tool has been used to calculate the 10 years CHD risk and traditional CVD risk factors have been assessed. Among 272 subjects, more than three quarters n = 244 subjects (89.7%), had projected 10 years risk of CHD risk < 10%. The outcome was quite different in a comparative study with total 691 subjects aged 30 to 70 years, n = 59 subjects (8.5%) had projected 10 year coronary heart disease risks > 30%, and 291 (42.1%) had risks >15%. 9 The mean Framingham risk estimation of participants in this study was 4.28 which are comparable with a study done on Iranian postmenopausal women with mean risk 1.46. The estimated 10 years risk for CHD was greater in this study, which could be because the mean age of the participants was high (mean age = 60.34 years) and it has adopted the calculator from the original
Framingham study but the performance of the scale in Asian population is not clear. 10 This study illustrates 20% of study population had TC > 211mg/dL and the occurrence (n = 146) of TC > 121mg/dL was in age group 50 to 59 years. 13 In this study, 59.92% (n = 163) (total n = 272) of participants had HDL less than 39, among this (n = 92) had 10years CHD risk between 1% to 5%. Who had menopause within l a s t o n e t o f i v e y e a r s ( n = 9 0 ) h a d 
